166 related articles for article (PubMed ID: 20044367)
1. Elevated International Normalized Ratio associated with concurrent use of ophthalmic erythromycin and warfarin.
Parker DL; Hoffmann TK; Tucker MA; Gerschutz GP; Malone PM
Am J Health Syst Pharm; 2010 Jan; 67(1):38-41. PubMed ID: 20044367
[TBL] [Abstract][Full Text] [Related]
2. Elevated international normalized ratio values associated with concomitant use of warfarin and ceftriaxone.
Clark TR; Burns S
Am J Health Syst Pharm; 2011 Sep; 68(17):1603-5. PubMed ID: 21856805
[TBL] [Abstract][Full Text] [Related]
3. Elevated international normalized ratio associated with use of dronedarone and warfarin.
Pogge EK; Haber SL
Ann Pharmacother; 2011 Sep; 45(9):e46. PubMed ID: 21811004
[TBL] [Abstract][Full Text] [Related]
4. Effect of carbamazepine initiation and discontinuation on antithrombotic control in a patient receiving warfarin: case report and review of the literature.
Parrish RH; Pazdur DE; O'donnell PJ
Pharmacotherapy; 2006 Nov; 26(11):1650-3. PubMed ID: 17064211
[TBL] [Abstract][Full Text] [Related]
5. Elevated international normalized ratio associated with concomitant warfarin and erlotinib.
Thomas KS; Billingsley A; Amarshi N; Nair BA
Am J Health Syst Pharm; 2010 Sep; 67(17):1426-9. PubMed ID: 20720241
[TBL] [Abstract][Full Text] [Related]
6. Probable interaction between warfarin and bee pollen.
Hurren KM; Lewis CL
Am J Health Syst Pharm; 2010 Dec; 67(23):2034-7. PubMed ID: 21098375
[TBL] [Abstract][Full Text] [Related]
7. Elevated International Normalized Ratio after concurrent ingestion of cranberry sauce and warfarin.
Mergenhagen KA; Sherman O
Am J Health Syst Pharm; 2008 Nov; 65(22):2113-6. PubMed ID: 18997138
[TBL] [Abstract][Full Text] [Related]
8. A potential interaction between warfarin and atovaquone.
Hidalgo K; Lyles A; Dean SR
Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
[TBL] [Abstract][Full Text] [Related]
9. Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer.
Lee R; Wen A; Berube C
Am J Health Syst Pharm; 2011 May; 68(9):814-7. PubMed ID: 21515865
[TBL] [Abstract][Full Text] [Related]
10. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.
Hylek EM; Regan S; Go AS; Hughes RA; Singer DE; Skates SJ
Ann Intern Med; 2001 Sep; 135(6):393-400. PubMed ID: 11560452
[TBL] [Abstract][Full Text] [Related]
11. Increased warfarin requirements in a patient with chronic hepatitis C infection receiving sofosbuvir and ribavirin.
Peterson D; Van Ermen A
Am J Health Syst Pharm; 2017 Jun; 74(12):888-892. PubMed ID: 28596225
[TBL] [Abstract][Full Text] [Related]
12. Elevated International Normalized Ratio associated with concurrent use of sorafenib and warfarin.
Moretti LV; Montalvo RO
Am J Health Syst Pharm; 2009 Dec; 66(23):2123-5. PubMed ID: 19923313
[TBL] [Abstract][Full Text] [Related]
13. Warfarin and acetaminophen interaction.
Gebauer MG; Nyfort-Hansen K; Henschke PJ; Gallus AS
Pharmacotherapy; 2003 Jan; 23(1):109-12. PubMed ID: 12523469
[TBL] [Abstract][Full Text] [Related]
14. Tolterodine-warfarin drug interaction.
Colucci VJ; Rivey MP
Ann Pharmacother; 1999 Nov; 33(11):1173-6. PubMed ID: 10573314
[TBL] [Abstract][Full Text] [Related]
15. A new regimen for starting warfarin therapy in out-patients.
Oates A; Jackson PR; Austin CA; Channer KS
Br J Clin Pharmacol; 1998 Aug; 46(2):157-61. PubMed ID: 9723825
[TBL] [Abstract][Full Text] [Related]
16. Elevated International Normalized Ratio in a patient concurrently using warfarin and vismodegib.
Lim S; Houranieh J; Crawford R
Am J Health Syst Pharm; 2014 Feb; 71(3):200-3. PubMed ID: 24429012
[TBL] [Abstract][Full Text] [Related]
17. Increasing warfarin dosage reductions associated with concurrent warfarin and repeated cycles of 5-Fluorouracil therapy.
Davis DA; Fugate SE
Pharmacotherapy; 2005 Mar; 25(3):442-7. PubMed ID: 15843293
[TBL] [Abstract][Full Text] [Related]
18. Leflunomide and warfarin interaction: case report and review of the literature.
Chonlahan J; Halloran MA; Hammonds A
Pharmacotherapy; 2006 Jun; 26(6):868-71. PubMed ID: 16716139
[TBL] [Abstract][Full Text] [Related]
19. Probable Interaction Between Warfarin and Divalproex Sodium.
Anderson SL; Marrs JC
J Pharm Technol; 2014 Feb; 30(1):8-12. PubMed ID: 34860893
[No Abstract] [Full Text] [Related]
20. Increase in international normalized ratio after smoking cessation in a patient receiving warfarin.
Evans M; Lewis GM
Pharmacotherapy; 2005 Nov; 25(11):1656-9. PubMed ID: 16232028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
